O'Brien Patrick sold ARWR
January 6, 2026 · Form 4 insider transaction
O'Brien Patrick sold 540 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
540
Price
$0.00
Total value
N/A
InsiderO'Brien Patrick
Role—
SecurityCommon Stock
Transaction codeG: Gift
Transaction dateJanuary 6, 2026
Filing dateJanuary 8, 2026
Shares owned after474,368
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Gift to relatives; Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions.